BROADCASTS.com

b'Credits: 0.25 AMA PRA Category 1 Credit\\u2122\\n\\xa0\\nCME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-263\\n\\xa0\\nOverview: The FDA\\u2019s recent emergency use authorization (EUA) for oral agents to treat COVID-19 means that primary care providers (PCPs) will be on the frontline of treating patients with COVID-19. Therefore, PCPs must understand who is eligible for such treatments and how to prescribe them. We will discuss the results of the recent FDA EUA for Pfizer\\u2019s Paxlovid and Merck\\u2019s molnupiravir antiviral agents and give you the information you need to confidently prescribe them.\\n\\xa0\\nEpisode resource links:\\nFACT SHEET FOR HEALTHCARE PROVIDERS: EMERGENCY USE AUTHORIZATION FOR MOLNUPIRAVIR (fda.gov)\\nFACT SHEET FOR HEALTHCARE PROVIDERS: EMERGENCY USE AUTHORIZATION FOR PAXLOVID (fda.gov)\\nGuest: Robert A. Baldor MD, FAAFP\\n\\xa0\\nMusic Credit: Richard Onorato'